Do it Right, by Not Doing it Yourself – the Value of a Good CDMO Partner

Partnering with a specialized CDMO can have many advantages especially for complex API like peptides or oligonucleotides.

01.03.22

Developing a new drug is a very complex process and only one in a hundred candidates make it from the bench to the market.

Partnering with a specialized Contract Development and Manufacturing Organization (CDMO) can have many advantages especially for complex API like peptides or oligonucleotides.

This lecture discusses the key benefits of such a collaboration and the trends and innovation in the market that aim at better serving the needs of the customers.

More Content From Do it Right, by Not Doing it Yourself – the Value of a Good CDMO Partner

[WEBINAR] Mitigating supply chain risks in an age of disruption

Tuesday, June 11, 2024

Sponsored Content Released on 05.23.2024
Bachem brings scientific expertise to Spring 2024 conferences

Bachem will use all three events to showcase its leading-edge capabilities as a peptide and oligonucleotide manufacturer.

News Releases Released on 03.15.2024
APIs | Biologics, Proteins, Vaccines | Drug Development

No More DMF: Greener Solid-Phase Peptide Synthesis With Binary Solvents [WATCH ON-DEMAND]

Learn how the polarity and viscosity profiles of binary solvents can be used to predict their utility for producing different peptides by SPPS.

Sponsored Content Released on 12.01.2023
[WEBINAR] Large-Scale TIDES Purification With MCSGP Under GMP

Join Bachem for a Virtual Event on Tuesday, December 5th, 2023.

News Releases Released on 11.22.2023
Back to Stirred Vessels and on to Metric Tons of Oligonucleotides

Scientists seek to discover new production routes when manufacturing limits arise.

Sponsored Content Released on 11.22.2023
Leading the Octreotide Scale-Up - A Generics Case Study

Bachem Develops a Cost-Effective, Large-Batch Process for Octreotide Acetate Synthesis

Case Studies Released on 11.08.2023
[WEBINAR] Tag-assisted one-pot liquid-phase oligonucleotide synthesis

The webinar will take place on November 15, 2023 at 11:00 AM ET / 8:00 AM PT / 17:00 CET

News Releases Released on 11.08.2023
Visit Bachem at CPhI Worldwide 2023

Bachem is participating in this global event and invite you to be inspired by their innovative and sustainable approaches to generic API manufacturing.

News Releases Released on 10.05.2023
APIs | Biologics, Proteins, Vaccines | Drug Development | Process Development

Peptide Aggregation – A Complex Topic [WATCH ON-DEMAND]

Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.

Sponsored Content Released on 10.02.2023
APIs | Process Development

High-Resolution Mass Spectrometry of Oligonucleotides – Characterization Made Easy [WATCH ON-DEMAND]

Direct, robust and easy-to-use techniques to fully characterize the nucleotide sequence of highly modified single-stranded RNAs by top down tandem MS.

Sponsored Content Released on 09.01.2023
Biologics, Proteins, Vaccines

Learn About Methods for Making Long and Complex Peptides

The pros and cons of today’s technologies for SPPS, native chemical ligation, CEPS, KAHA and recombinant technologies.

Sponsored Content Released on 08.16.2023
APIs | Scale-up/Technology Transfer

Scalable Oligonucleotide Manufacture with Stirred-Bed Technology [WATCH ON-DEMAND]

Learn how to reach commercial oligonucleotides API production in metric ton range with unbeaten process mass intensity and much more.

Sponsored Content Released on 08.04.2023
APIs

How to increase sustainability for large-scale peptide API purification

The peptide drug market has experienced significant growth in recent years and is expected to continue its upward trend in the coming years.

White Papers / Tech Papers Released on 08.01.2023
APIs

Solid Phase Peptide Synthesis Explained

Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis.

Sponsored Content Released on 06.28.2023
APIs | Drug Development

Manufacturing Complex Peptide APIs

An interview with Sergey Malashikhin of Bachem on what’s behind the manufacturing of complex APIs.

Sponsored Content Released on 05.31.2023